In November 2018, the ACC/AHA released new guidelines for cholesterol management. Now, in August 2019, the Joint European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Task Force has followed with a much-needed update to the 2016 Dyslipidaemia Guidelines.

PCSK9 Forum asked US experts to compare the two sets of guidelines: Is there more convergence than divergence?

Dr. Robert P. Giugliano, Brigham and Women’s Hospital and Harvard Medical School. Dr Giugliano is also a senior investigator of the Thrombolysis in Myocardial Infarction (TIMI) Study Group.

Watch Dr. Giugliano’s perspective »

Professor Gregory G. Schwartz, School of Medicine, University of Colorado, USA. Professor Schwartz is also Co-Principal Investigator of the ODYSSEY OUTCOMES Study.

Watch Prof. Schwartz’s perspective »

Finally, Professor François Mach (Geneva University Hospital, Geneva, Switzerland), a Joint Chair of the 2019 ESC/EAS Dyslipidaemia Guidelines gives his three key messages for clinicians

Watch the video »

Education: the primary mission of PCSK9 Forum.

Don’t forget to check back for the latest updates to the PCSK9 Forum educational slide resource programme